CTLA4 and colorectal carcinoma: Herein, we aimed to understand the role of in situ vaccination (ISV)-based immunotherapy using our calreticulin nanoparticle (CRT-NP) and its correlation with anti-CTLA-4 therapeutic outcomes in mice bearing Colorectal cancer (CRC).